生物技術 業務的一部分 生命科學.
生物技術之智財保護的前導
50多年的執業中,Finnegan飛翰與生技領域的先驅廠商合作,制訂與執行成功的智財策略,包括就突破性進步取得專利,透過訴訟實施專利權,以及針對他人侵權與所有權的指控作辯護。我們代表禮來公司,在世界首推的生物科技產品(人工胰島素) 的訴訟案獲得勝訴,並且就一系列的生物技術提供諮詢或訴訟的服務,像是DNA自動定序,桃莉羊的複製,檢測胚胎染色體數異常的非侵入性方法,以及抗體平台設計。
了解法律,科學,和技術
強健的智財保護對於生技產業的推動是不可或缺的,並且依舊為其持續發展的關鍵。身為由科學家和生物技術工程師組成的智財權律師事務所,Finnegan期許能與科技的快速發展,和這個跨領域產業中不斷變化的法律議題齊頭並進。
隨著生技領域客戶以我們尚未想到的方式取得振奮人心的突破,我們透過以下方式提供協助:
我們在既有和新興領域與客戶合作,包括:
保護創新之全面的法律,技術,和策略經驗
我們的生命科學業務由250多位律師和專業人士組成,致力於滿足客戶對於智財權服務的需求。多數擁有與生物學,化學,生物化學,醫學,藥理學,或生醫工程等相關學科的高階學位。大多具有紮實的研究和/或產業經驗,許多人在產業或大學任職,或在美國專利商標局擔任審查委員後加入Finnegan飛翰。
2:23-cv-00094, 2:23-cv-02364, D.N.J., Judges Cecchi, Padin, Wettre
IPR2022-01200, PGR2022-00051, PTAB, Judges Newman, Snedden, Wisz
22-2232, Fed. Cir.
PGR2022-00037, PTAB, Judges Newman, Obermann, Worth
IPR2022-00738, -00739, -00796, PTAB, Judges Cotta, Wisz, Worth
1:21-cv-10954, D. Mass., Judge Burroughs
T 0527/17, EPO
Workshop
Life Sciences Workshop: Updates and Key Trends in Pharmaceutical and Biotechnology IP Law
May 2, 2024
Cambridge
Conference
2nd Annual Forum on IP, Funding and Tech Strategies for Novel Therapeutic Modalities
March 20, 2024
Boston
Webinar
February 15, 2024
Webinar
Press Release
Finnegan Continues to Hold Top-Tier LMG Life Sciences 2022 Rankings
September 22, 2022
Press Release
ITC Determines Healthgen’s Medium Grade Products Did Not Infringe Ventria’s Patent
September 16, 2022
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.